Impact of PCR for respiratory viruses on antibiotic use: theory and practice
- PMID: 21194137
- PMCID: PMC7167622
- DOI: 10.1002/ppul.21385
Impact of PCR for respiratory viruses on antibiotic use: theory and practice
Abstract
Rationale for the study: Real-time polymerase chain reaction (PCR) for respiratory viruses is more sensitive, yet more expensive, than conventionally used direct immunofluorescence (DIF). We determined the impact of real-time PCR, additional to DIF, on antibiotic prescription in ventilated children with lower respiratory tract infection (LRTI) at admission to the pediatric intensive care unit (PICU).
Methods: First, a multicenter survey study was performed. Subsequently, in a prospective study, children (≤ 5 years) with LRTI were tested at admission by DIF and PCR. Positive DIF results were reported at the end of the first working day. PICU physicians reported antibiotic treatment on the second working day. After informing them of the PCR result antibiotic treatment was reevaluated.
Results: The multicenter survey study (94 respondents) showed that PCR decreased antibiotic use (P < 0.001). In the prospective study 38 children were included, of which 19 (50%) were DIF positive. Of the 19 DIF negative patients 12 (63%) were treated with antibiotics before revealing the PCR result; the PCR test was positive in 9 out of 12. Revealing PCR results did not alter antibiotic treatment. In 7 DIF negative patients antibiotics not given, the PCR test was positive.
Conclusion: In contrast to their responses to the survey study, in real-life PICU physicians did not let their antibiotic prescription be influenced by respiratory real-time PCR in children ventilated for LRTI.
Keywords: anti-bacterial agents; patient care management; pediatric intensive care units; questionnaires; real-time polymerase chain reaction; viral lower respiratory tract infections.
Copyright © 2010 Wiley-Liss, Inc.
Figures


References
-
- Paramore LC, Mahadevia PJ, Piedra PA. Outpatient RSV lower respiratory infections among high‐risk infants and other pediatric populations. Pediatr Pulmonol 2010; 45: 578–584. - PubMed
-
- Randolph AG, Meert KL, O'Neil ME, Hanson JH, Luckett PM, Arnold JH, Gedeit RG, Cox PN, Roberts JS, Venkataraman ST, Forbes PW, Cheifetz IM. The feasibility of conducting clinical trials in infants and children with acute respiratory failure. Am J Respir Crit Care Med 2003; 167: 1334–1340. - PubMed
-
- Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis‐associated hospitalizations among US children, 1980–1996. JAMA 1999; 282: 1440–1446. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical